The Europe cardiopulmonary oxygenator market was valued at US$ 215.48 million in 2022 and is expected to reach US$ 265.89 million by 2028. It is estimated to register a CAGR of 3.6% from 2022 to 2028
According to the World health organization (WHO), COPD was the third prominent cause of death worldwide in 2021. The high mortality rate of COPD is associated with acute exacerbations that lead to the failure of patients’ respiratory muscles, resulting in the loss of their ability to breathe independently; thus, the patients die from systemic infection and asphyxia. Oxygenator devices can be used to manage COPD attacks. Thus, with the growing incidence of COPD, the demand for cardiopulmonary oxygenators is also on the rise.
The primary risk factors of CVDs include family history, ethnicity, and age; other risk factors include tobacco consumption, hypertension, obesity, high cholesterol, physical inactivity, and diabetes. The WHO estimates 17.9 million lives are lost due to CVDs annually. To prevent patients’ death, oxygenator devices can be a major assistance to doctors. In the case of heart failure, the oxygen level in the blood is maintained with the help of an external device as the heart cannot maintain proper oxygen levels. Oxygenator devices are used to manage heart failure patients.
Thus, the increasing prevalence of cardiopulmonary diseases (cardiovascular disorders and COPDs) boosts the demand for cardiopulmonary oxygenators.
In Europe, heart attack is the most serious consequence of coronary heart disease (CHD). In Germany, more than 3.6 million people live with CHD, and more than 1.3 million have survived a stroke. Their prevalence is also on the rise. According to the latest WHO data published in 2020, Coronary Heart Disease Deaths in Germany reached 147,055 or 20.98% of total deaths. Moreover, chronic obstructive pulmonary disease (COPD) has a high prevalence rate in Europe, and a further increase is expected within the next years. Further, in 2020, the number of isolated heart transplantations increased to 340, a rise of 2.1% compared with the previous year. However, the isolated lung transplantations amounted to 291, a decrease of 6.4%. During the surgery to treat cardiopulmonary diseases, oxygenators are used to decrease the pressure on lung and heart. Therefore, rising cases of cardiopulmonary diseases in Europe is fueling the growth of the cardiopulmonary oxygenators market.
Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022.
Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.
Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.
Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.
Based on country, the market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the market share in 2022.
Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Eurosets SRL; Microport Scientific Corp; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the Cardiopulmonary Oxygenator Market in the region.
Rise in Incidence of Cardiopulmonary Diseases is Fueling Europe Cardiopulmonary Oxygenator Market
Cardiopulmonary disorders mainly affect the lungs and heart of people. These conditions are categorized as cardiovascular diseases and chronic obstructive pulmonary disease (COPD). Cardiovascular diseases include coronary artery diseases, blood vessel diseases, heart arrhythmia problems, and heart defects, which affect the heart and blood vessels. Further, COPDs are diagnosed with emphysema and chronic bronchitis.According to the World health organization (WHO), COPD was the third prominent cause of death worldwide in 2021. The high mortality rate of COPD is associated with acute exacerbations that lead to the failure of patients’ respiratory muscles, resulting in the loss of their ability to breathe independently; thus, the patients die from systemic infection and asphyxia. Oxygenator devices can be used to manage COPD attacks. Thus, with the growing incidence of COPD, the demand for cardiopulmonary oxygenators is also on the rise.
The primary risk factors of CVDs include family history, ethnicity, and age; other risk factors include tobacco consumption, hypertension, obesity, high cholesterol, physical inactivity, and diabetes. The WHO estimates 17.9 million lives are lost due to CVDs annually. To prevent patients’ death, oxygenator devices can be a major assistance to doctors. In the case of heart failure, the oxygen level in the blood is maintained with the help of an external device as the heart cannot maintain proper oxygen levels. Oxygenator devices are used to manage heart failure patients.
Thus, the increasing prevalence of cardiopulmonary diseases (cardiovascular disorders and COPDs) boosts the demand for cardiopulmonary oxygenators.
Europe Cardiopulmonary Oxygenator Market Overview
The European cardiopulmonary oxygenator market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the cardiopulmonary oxygenator market.In Europe, heart attack is the most serious consequence of coronary heart disease (CHD). In Germany, more than 3.6 million people live with CHD, and more than 1.3 million have survived a stroke. Their prevalence is also on the rise. According to the latest WHO data published in 2020, Coronary Heart Disease Deaths in Germany reached 147,055 or 20.98% of total deaths. Moreover, chronic obstructive pulmonary disease (COPD) has a high prevalence rate in Europe, and a further increase is expected within the next years. Further, in 2020, the number of isolated heart transplantations increased to 340, a rise of 2.1% compared with the previous year. However, the isolated lung transplantations amounted to 291, a decrease of 6.4%. During the surgery to treat cardiopulmonary diseases, oxygenators are used to decrease the pressure on lung and heart. Therefore, rising cases of cardiopulmonary diseases in Europe is fueling the growth of the cardiopulmonary oxygenators market.
Exhibit: Europe Cardiopulmonary Oxygenator Market Revenue and Forecast to 2028 (US$ Million)
Europe Cardiopulmonary Oxygenator Market Segmentation
The Europe cardiopulmonary oxygenator market is segmented into product, application, type, age group, end use, and country. Based on product, the market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2022.Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022.
Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.
Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.
Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.
Based on country, the market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the market share in 2022.
Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Eurosets SRL; Microport Scientific Corp; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the Cardiopulmonary Oxygenator Market in the region.
Table of Contents
1. Introduction
3. Research Methodology
4. Europe Cardiopulmonary Oxygenator Market - Market Landscape
5. Europe Cardiopulmonary Oxygenators Market - Key Market Dynamics
6. Cardiopulmonary Oxygenators Market - Europe Analysis
7. Europe Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Product
8. Europe Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Application
9. Europe Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Type
10. Europe Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Age Group
11. Europe Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by End Use
12. Europe Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Country Analysis
13. Europe Cardiopulmonary Oxygenators Market-Industry Landscape
14. Company Profiles
15. Appendix
List of Tables
List of Figure
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Getinge AB
- LivaNova Plc
- Medtronic Plc
- Terumo Corp
- Eurosets SRL
- Microport Scientific Corp
- Chalice Medical Ltd
- Fresenius Medical Care AG & Co KGaA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 118 |
| Published | July 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 215.48 million |
| Forecasted Market Value ( USD | $ 265.89 million |
| Compound Annual Growth Rate | 3.6% |
| Regions Covered | Europe |
